肾交感神经阻断术的全球市场（2023-2030）：按类型（导管、射频产生器）和技术（高频、超音波）分類的规模、份额、成长分析和预测

全球肾交感神经阻断术市场规模将从2021年的2,1949万美元成长到2022年的3,0882万美元，预测期内年复合成长率为40.7%，到2030年将成长到107477万美元。

全球肾交感神经阻断术市场近年来经历了显着成长，预计未来将保持上升趋势。肾交感神经阻断术市场的成长是由全球高血压盛行率的增加以及人们对去肾交感神经阻断术的益处的认识不断提高所推动的。与高血压相关的健康问题日益严重，增加了对有效替代疗法（如肾交感神经阻断术）的需求。其他好处包括减少对药物治疗的依赖和改善患者的治疗结果，从而导致医疗保健专业人员和患者越来越多地采用该药物。此外，医疗设备的技术进步也在推动市场成长方面发挥着重要作用。肾交感神经阻断术手术现在结合了具有射频或超音波能量的创新导管系统，以选择性地消融肾神经。这些技术改进提高了程序的准确性和安全性，进一步促进了其采用。

然而，另一方面，肾交感神经阻断术市场仍存在一些问题。一个主要障碍是缺乏长期临床资料来证实手术的持续有效性和安全性。儘管早期研究已显示出有希望的结果，但仍需要更多证据来确定肾交感神经阻断术作为高血压的标准治疗方法。

本报告调查了全球肾交感神经阻断术市场，并提供了市场概况、市场各种影响因素分析、技术和创新趋势、法律制度、市场规模趋势和预测，以及按不同细分市场和地区进行的细分。总结了主要企业的细分、竞争形势和概况。

目录

• 执行摘要
• 调查方法
• 母市场分析
  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
• 关键市场洞察
  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • 启动分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 重点投资分析
  • 关键成功因素
  • 竞争程度
  • 市场动态及展望
    • 市场动态
      • 促进因素
      • 机会
      • 抑制因素
      • 任务
  • 法规状况
  • 波特的分析
  • Skyquest 对未来颠覆的独家见解
• 全球肾交感神经阻断术市场：按类型
  • 市场概况
  • 导管
  • 射频发生器
  • 神经调节剂
• 全球肾交感神经阻断术市场：依技术分类
  • 市场概况
  • 高频
  • 超音波
  • 微量输液
• 全球肾交感神经阻断术市场：按地区
  • 市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲
• 竞争形势
  • 前5名企业对比
  • 主要企业市场地位
  • 主要企业的招募策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率
• 主要企业简介
  • Medtronic
  • Boston Scientific Corporation
  • ReCor Medical
  • Ablative Solutions
  • Mercator MedSystems
  • Terumo Corporation
  • St. Jude Medical (Abbott Laboratories)
  • CardioSonic
  • Symple Surgical
  • Soundbite Medical Solutions
  • Vessix Vascular (Boston Scientific)
  • Renal Dynamics (Boston Scientific)
  • Kona Medical
  • Ablacon
  • Cardiosonic Ltd.
  • EndoCross Ltd.
  • Caldus Medical
  • OxSonics
  • Nexeon MedSystems
  • Johnson & Johnson

Global Renal Denervation Market size was valued at USD 219.49 million in 2021 and is poised to grow from USD 308.82 million in 2022 to USD 1,074.77 million by 2030, at a CAGR of 40.7% during the forecast period (2023-2030).

The global market for renal denervation has experienced significant growth in recent years and is poised to maintain its upward trajectory. Renal denervation is a minimally invasive medical procedure employed to manage hypertension, targeting the renal nerves responsible for regulating blood pressure. The market's expansion is driven by the increasing prevalence of hypertension on a global scale and a growing awareness of the advantages associated with renal denervation. A key driving force behind the renal denervation market is the rising incidence of hypertension, a major contributor to cardiovascular diseases. Given the ongoing global health concern surrounding hypertension, there is a mounting demand for effective treatment alternatives like renal denervation. Additionally, the procedure offers numerous benefits, including reduced reliance on medication and enhanced patient outcomes, thereby prompting its adoption by healthcare providers and patients alike. Moreover, technological advancements in medical devices have played a significant role in driving market growth. Renal denervation procedures now incorporate innovative catheter systems equipped with either radiofrequency or ultrasound energy for the selective ablation of renal nerves. These technological enhancements have heightened the precision and safety of the procedure, further stimulating its adoption. However, challenges confront the renal denervation market. A prominent obstacle is the absence of long-term clinical data confirming the sustained efficacy and safety of the procedure. While initial studies have shown promising results, additional evidence is required to establish renal denervation as a standard treatment option for hypertension.

Top-down and bottom-up approaches were used to estimate and validate the size of the global renal denervation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

Global Renal Denervation Market is segmented on the basis of type, technology, and region. By type, the market is segmented into catheters, RF generators, and nerve modifying agents. By technology, the market is segmented into radiofrequency, ultrasound, and micro-infusion. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers:

Technological Advancements

The growth of the market is being propelled by developments in renal denervation technologies, which encompass refined catheter designs, more efficient energy delivery systems, and novel agents for modifying nerves. These innovations significantly improve the procedure's accuracy, safety, and overall effectiveness.

Growing Awareness and Acceptance

The growth of the market is being propelled by a rising awareness of the advantages of renal denervation among both patients and healthcare professionals. This procedure provides benefits that include a decreased need for medication, enhanced management of blood pressure, and the potential for long-term positive outcomes.

Restraints:

Limited Awareness and Adoption in Emerging Markets

Limited awareness and comprehension of renal denervation as a hypertension treatment option may exist in certain developing markets. This deficiency in knowledge, when combined with inadequate healthcare infrastructure, can act as hindrances to market expansion in these areas.

Procedural Complexity and Learning Curve

Renal denervation is a procedure characterized by its technical intricacy, demanding specialized training and proficiency. The intricacies of the procedure and the time it takes to become proficient in it may restrict its widespread utilization, particularly among healthcare providers who are less experienced in this field.

Market Trends:

Transition to Outpatient Renal Denervation: There is an emerging tendency to conduct renal denervation procedures in outpatient or ambulatory settings as opposed to traditional hospital environments. This transition is motivated by factors such as cost-efficiency, patient convenience, and a reduction in the need for hospitalization. Shifting renal denervation to ambulatory settings can expand patient accessibility and promote market growth.

Patient-Focused Strategy: Healthcare providers and entities within the renal denervation sector are increasingly embracing a patient-centric strategy. The emphasis is on delivering customized care, enhancing patient outcomes, and elevating the patient experience throughout the entire renal denervation process. This trend corresponds with the broader movement towards value-based healthcare.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Renal Denervation Market by Type
  • Market Overview
  • Catheters
  • RF generators
  • and nerve modifying agents
• Global Renal Denervation Market by Technology
  • Market Overview
  • Radiofrequency
  • ultrasound
  • and micro-infusion
• Global Renal Denervation Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Medtronic - Ireland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Boston Scientific Corporation - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • ReCor Medical - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ablative Solutions - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mercator MedSystems - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Terumo Corporation - Japan
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • St. Jude Medical (Abbott Laboratories) - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • CardioSonic - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Symple Surgical - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Soundbite Medical Solutions - Canada
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Vessix Vascular (acquired by Boston Scientific) - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Renal Dynamics (acquired by Boston Scientific) - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Kona Medical - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ablacon - Germany
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Cardiosonic Ltd. - Israel
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • EndoCross Ltd. - Israel
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Caldus Medical - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • OxSonics - United Kingdom
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Nexeon MedSystems - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Johnson & Johnson - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments